Overview

Toradol to Reduce Ureteroscopic Symptoms Trial

Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Treatments:
Ketorolac
Ketorolac Tromethamine